A multicenter cross-sectional study in Nature Medicine shows serum p-tau—the cornerstone of Alzheimer's blood-based diagnostics—may also detect systemic amyloidoses....

A pattern I’ve been tracking across my patient panel for the past several months: the patients most likely to...

A trial emulation study of 174,678 type 1 diabetes patients shows GLP-1RAs cut major cardiovascular events and end-stage kidney...

Seven of ten patients remained alive 19–37 months after a single intratumoral injection of ultra‑high concentration nitric oxide (UNO)...

Serina Therapeutics just closed a $30 million private placement at a 68% premium to fund a registrational trial for...

Astellas's ILUSTRO trial just published Phase 2 data showing a zolbetuximab-nivolumab-mFOLFOX6 triplet in CLDN18.2-positive gastric cancer produces response rates...

EMANATE, a global Phase 3 study of setmelanotide across four heterozygous MC4R-pathway genetic subgroups, missed its primary endpoint of...

Preclinical data point to restored GNE protein expression and increased sialic acid production following intravenous delivery of a dual-function...

At Week 104 of the pivotal ApproaCH trial in children with achondroplasia, once-weekly TransCon CNP (navepegritide) maintained gains in...

Propanc Biopharma has signed a services agreement with Berlin-based FyoniBio to develop and validate an LC-MS pharmacokinetics assay capable...